Cormark Issues Positive Estimate for OTCMKTS:GTBIF Earnings

Key Points

• Cormark has raised their FY2026 earnings estimate for Green Thumb Industries Inc. to $0.18 per share, up from $0.15, contrasting with the consensus estimate of $0.32 per share.
• In its latest quarterly results, Green Thumb reported an earnings per share of ($0.01), missing analyst expectations, but exceeding revenue estimates with $293.26 million.
• Benchmark has reaffirmed a "buy" rating for Green Thumb Industries, reflecting a positive outlook for the company's stock.

Green Thumb Industries Inc. (OTCMKTS:GTBIF - Free Report) - Cormark increased their FY2026 earnings estimates for Green Thumb Industries in a report issued on Monday, August 11th. Cormark analyst J. Pytlak now forecasts that the company will post earnings of $0.18 per share for the year, up from their previous estimate of $0.15. The consensus estimate for Green Thumb Industries' current full-year earnings is $0.32 per share.

Green Thumb Industries (OTCMKTS:GTBIF - Get Free Report) last posted its quarterly earnings results on Wednesday, August 6th. The company reported ($0.01) EPS for the quarter, missing analysts' consensus estimates of $0.04 by ($0.05). The company had revenue of $293.26 million during the quarter, compared to the consensus estimate of $280.66 million. Green Thumb Industries had a return on equity of 1.62% and a net margin of 2.51%.

Separately, Benchmark reaffirmed a "buy" rating on shares of Green Thumb Industries in a research report on Monday.

Green Thumb Industries Price Performance

Shares of Green Thumb Industries stock opened at $8.27 on Wednesday. Green Thumb Industries has a 1 year low of $4.63 and a 1 year high of $12.00. The firm's 50-day moving average is $5.82 and its two-hundred day moving average is $6.01. The stock has a market cap of $1.75 billion, a price-to-earnings ratio of 75.14 and a beta of 1.18.

Green Thumb Industries Company Profile

Green Thumb Industries Inc manufactures, distributes, markets, and sells of cannabis products for medical and adult-use in the United States. It operates through two segments, Retail and Consumer Packaged Goods. The company offers cannabis flower; processed and packaged products, including pre-rolls, concentrates, vapes, capsules, tinctures, edibles, topicals, and other cannabis-related products under the &Shine, Beboe, Dogwalkers, Doctor Solomon's, Good Green, incredibles, and RHYTHM brands.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.